Calamos Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Hold |
|
|||||
|
2025
Q1 | $12.3M | Buy |
|
|||||
|
2024
Q4 | $12.4M | Buy |
|
|||||
|
2024
Q3 | $11.1M | Sell |
|
|||||
|
2024
Q2 | $15.9M | Sell |
|
|||||
|
2024
Q1 | $17M | Sell |
|
|||||
|
2023
Q4 | $13.9M | Sell |
|
|||||
|
2023
Q3 | $12.9M | Hold |
|
|||||
|
2023
Q2 | $17.5M | Sell |
|
|||||
|
2023
Q1 | $15.4M | Sell |
|
|||||
|
2022
Q4 | $16.1M | Sell |
|
|||||
|
2022
Q3 | $26.8M | Buy |
|
|||||
|
2022
Q2 | $30.8M | Sell |
|
|||||
|
2022
Q1 | $40M | Buy |
|
|||||
|
2021
Q4 | $40M | Sell |
|
|||||
|
2021
Q3 | $35.9M | Buy |
|
|||||
|
2021
Q2 | $30.1M | Buy |
|
|||||
|
2021
Q1 | $22.1M | Sell |
|
|||||
|
2020
Q4 | $26.7M | Buy |
|
|||||
|
2020
Q3 | $14.1M | Sell |
|
|||||
|
2020
Q2 | $12.8M | Sell |
|
|||||
|
2020
Q1 | $12M | Sell |
|
|||||
|
2019
Q4 | $21.4M | Sell |
|
|||||
|
2019
Q3 | $27.5M | Sell |
|
|||||
|
2019
Q2 | $47M | Buy |
|
|||||
|
2019
Q1 | $43.2M | Sell |
|
|||||
|
2018
Q4 | $34.6M | Buy |
|
|||||
|
2018
Q3 | $24.3M | Buy |
|
|||||
|
2018
Q2 | $16.1M | Buy |
|
|||||
|
2018
Q1 | $13.1M | Buy |
|
|||||
|
2017
Q4 | $4.49M | Sell |
|
|||||
|
2017
Q3 | $4.57M | Buy |
|
|||||
|
2017
Q2 | $4.79M | Buy |
|
|||||
|
2017
Q1 | $3.59M | Sell |
|
|||||
|
2016
Q4 | $24.8M | Sell |
|
|||||
|
2016
Q3 | $45.7M | Buy |
|
|||||
|
2016
Q2 | $2.84M | Sell |
|
|||||
|
2016
Q1 | $4.17M | Buy |
|
|||||
|
2015
Q4 | $3.5M | Hold |
|
|||||
|
2015
Q3 | $3.15M | Buy |
|
|||||
|
2015
Q2 | $3.15M | Sell |
|
|||||
|
2015
Q1 | $3.33M | Buy |
|
|||||
|
2014
Q4 | $1.6M | Buy |
|
|||||
|
2014
Q3 | $1.28M | Hold |
|
|||||
|
2014
Q2 | $1.07M | Hold |
|
|||||
|
2014
Q1 | $927K | Hold |
|
|||||
|
2013
Q4 | $822K | Hold |
|
|||||
|
2013
Q3 | $870K | Hold |
|
|||||
|
2013
Q2 | $840K | Buy |
|